Norris Medicines Limited was established as a private limited company in the state of Maharashtra on 7th September 1990. The company commenced commercial operations in November 1991 with the commissioning of the formulations unit. The unit was set up at a total capacity outlay of Rs 135.85 lakhs, which was financed by equity contribution from the promoters and associates to the extent of Rs 108.12 lakhs and term loan of Rs 27.73 lakhs from Gujarat State Finance Corporation. Norris was converted into a public limited company with effect from 7th March 1992.
1990
Launch of Norris
1992
Launch of Ethical Division and conversion of company into Public Limited company
1994
WHO cGMP Certificate
1995
Major Expansions
1996
Started exporting to European, Middle East, Far East and African Countries
2000
The Company has decided to issue 1,80,00,000 No. of equity shares of Rs. 10 each on preferential/private placement basis at a price not less than Rs. 10 per share to PHC Holdings Ltd., 90,00,000 shares and Positive Healthcare (Asia) Ltd.
2006
-Launching of Diabetic & Cardiac products
2007
- Launching of Dental product range
2012
-Launching of New Molecule Tolperisone with Paracetamol tablet
2013
-Extension in Anti malarial range with Artemether Lumefantrine tablet & dry syrup
Click it and Unblock the Notifications
Sign in with Google